Form 8-K Freenome, Inc. For: Jul 27
false0002017526NASDAQ00020175262026-07-272026-07-270002017526dei:FormerAddressMember2026-07-272026-07-27
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event... (continue reading...)
Form 8-K California BanCorp \ CA For: Jul 23
false
0001795815
0001795815
2026-07-23
2026-07-23
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of... (continue reading...)
Form 8-K AIRWA INC. For: Jul 27
false
0001674440
0001674440
2026-07-27
2026-07-27
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities... (continue reading...)
Form 6-K NOVO NORDISK A S For: Jul 27
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
________________
FORM 6-K
________________
REPORT OF FOREIGN PRIVATE ISSUER
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of 1934
July 27, 2026
________________
NOVO NORDISK A/S
(Exact name of Registrant as specified in its charter)
Novo Allé 1
DK- 2880, Bagsvaerd
Denmark
(Address of principal executive offices)
________________
Form 8-K PITNEY BOWES INC /DE/ For: Jul 21
0000078814false00000788142026-07-212026-07-210000078814us-gaap:CommonStockMember2026-07-212026-07-210000078814pbi:A6.70Notesdue2043Member2026-07-212026-07-21UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 July 21, 2026Date of Report (Date of earliest event reported) Pitney Bowes Inc. (Exact name of registrant as specified in its charter)Delaware... (continue reading...)
More SEC Filings
View Older Stories-
Form 8-K OFA Group For: Jul 27
-
Form 8-K HOPE BANCORP INC For: Jul 27
-
Form 8-K SPRUCE BIOSCIENCES, INC. For: Jul 27
-
Form 8-K CytomX Therapeutics, For: Jul 24
-
Form 8-K Alpha Metallurgical Reso For: Jul 27
-
Form 424B3 Jaguar Health, Inc.
-
Form 8-K KIDZ AI Inc. For: Jul 27
-
Form 8-K ALLIANCE RESOURCE PARTNE For: Jul 27
-
Form 4 ClearBridge Energy Midst For: Jul 23 Filed by: AMERICAN GENERAL LIFE INSURANCE CO
-
Form 6-K Immuron Ltd For: Jul 27
-
Form 8-K Brookfield Asset Managem For: Jul 27
-
Form 8-K Strategy Inc For: Jul 27
-
Form 8-K CADIZ INC For: Jul 27
-
Form 8-K Kyverna Therapeutics, For: Jul 23
-
Form 424B3 Jaguar Health, Inc.
-
Form 8-K Strive, Inc. For: Jul 27
-
Form 8-K Arax Holdings Corp For: Jul 27
-
Form 6-K DHT Holdings, Inc. For: Jul 27
-
Form 6-K Hesai Group For: Jul 27
-
Form SCHEDULE 13G Eloxx Pharmaceuticals, Filed by: Aberdeen Group plc
-
Form D Gaingels Steel Robotics
-
Form 6-K NOKIA CORP For: Jul 27
-
Form 4 Fortrea Holdings Inc. For: Jul 20 Filed by: Smith David Ross
-
Form 6-K ASTRAZENECA PLC For: Jun 30
-
Form 13F-NT Pozavarovalnica Sava, For: Jun 30
-
Form 13F-HR DT Investment Partners, For: Jun 30
-
Form S-3ASR DBV Technologies S.A.
-
Form 425 Planet 13 Holdings Inc. Filed by: Planet 13 Holdings Inc.
-
Form 8-K Planet 13 Holdings Inc. For: Jul 26
-
Form 6-K KE Holdings Inc. For: Jul 27
-
Form D/A Hedge Fund Select: The
-
Form 6-K AURORA CANNABIS INC For: Jul 27
-
Form 8-K PRECISION BIOSCIENCES For: Jul 23
-
Form 8-K Boost Run Inc. For: Jul 27
-
Form 8-K Ponce Financial Group, For: Jul 27
-
Form 6-K SMITH & NEPHEW PLC For: Jul 27
-
Form D/A Hedge Fund Select: Symme
-
Form 13F-HR Spear Holdings RSC Ltd For: Jun 30
-
Form SCHEDULE 13D/A Evogene Ltd. Filed by: L.I.A. Pure Capital Ltd
-
Form 3 Ionetix Corp / DE / For: May 18 Filed by: Tarnok Michael P.
-
Form 13F-HR PBCay One RSC Ltd For: Jun 30
-
Form 6-K Costamare Inc. For: Jul 24
-
Form 8-K TransDigm Group INC For: Jul 27
-
Form 6-K FURY GOLD MINES LTD For: Jul 27
-
Form DEFA14A XCF Global, Inc.
-
Form 8-K MapLight Therapeutics, For: Jul 27
-
Form 6-K ASTRAZENECA PLC For: Jul 27
-
Form 8-K Neumora Therapeutics, For: Jul 27
-
Form 8-K XCF Global, Inc. For: Jul 27
-
Form 6-K Alithya Group inc For: Jul 27

